FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016385907> ?p ?o ?g. }

• W2016385907 endingPage "312" @default.
• W2016385907 startingPage "306" @default.
• W2016385907 abstract "PURPOSES OF REVIEW: Metabolic features of protease inhibitors, nonnucleoside reverse transcriptase inhibitors and rifamycins are known to significantly affect the possibility of coadministration of these compounds in HIV/tuberculosis dual infected subjects. In this review recent findings of drug-drug interactions between antiretroviral and antituberculous agents will be discussed.While protease inhibitors were confirmed to be not compatible with rifampin-containing anti-tuberculosis regimens, in the last year promising data were obtained for existing nonnucleoside reverse transcriptase inhibitors. Nevirapine, particularly, was shown to be safe and effective at standard dosing when associated with rifampin in Asian and African populations, suggesting a pharmacogenetics-based interindividual variability of interaction. On the other hand, although the interaction profile of new antiretrovirals, such as integrase inhibitors, entry inhibitors and most recent nonnucleoside reverse transcriptase inhibitors, has not yet been fully investigated, potential clinical problems of compatibility with rifamycins could be anticipated.Rifampin-containing antituberculous regimens seem compatible with nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapies, although the need for dose adjustments of the latter probably varies on individual basis. Pharmacogenetics studies aimed to define a possible strategy of posological individualization are warranted, especially for developing countries where nonnucleoside reverse transcriptase inhibitors s are the main antiretroviral option. The newly marketed drugs and drugs under development in both anti-HIV and anti-tuberculosis settings seem not to be devoid of these pharmacological interactions." @default.
• W2016385907 created "2016-06-24" @default.
• W2016385907 creator A5021206943 @default.
• W2016385907 creator A5052366087 @default.
• W2016385907 date "2008-05-01" @default.
• W2016385907 modified "2023-09-27" @default.
• W2016385907 title "Interactions between antiretroviral agents and those used to treat tuberculosis" @default.
• W2016385907 cites W1964545773 @default.
• W2016385907 cites W1998690882 @default.
• W2016385907 cites W1998739651 @default.
• W2016385907 cites W1998765853 @default.
• W2016385907 cites W2002011163 @default.
• W2016385907 cites W2011578101 @default.
• W2016385907 cites W2020276386 @default.
• W2016385907 cites W2030265729 @default.
• W2016385907 cites W2032729998 @default.
• W2016385907 cites W2046283526 @default.
• W2016385907 cites W2046677139 @default.
• W2016385907 cites W2051978736 @default.
• W2016385907 cites W2053229417 @default.
• W2016385907 cites W2062975680 @default.
• W2016385907 cites W2065376211 @default.
• W2016385907 cites W2067284686 @default.
• W2016385907 cites W2075257594 @default.
• W2016385907 cites W2089663335 @default.
• W2016385907 cites W2092534615 @default.
• W2016385907 cites W2096624362 @default.
• W2016385907 cites W2097185879 @default.
• W2016385907 cites W2106291638 @default.
• W2016385907 cites W2106737113 @default.
• W2016385907 cites W2112124041 @default.
• W2016385907 cites W2116247497 @default.
• W2016385907 cites W2116370212 @default.
• W2016385907 cites W2119493899 @default.
• W2016385907 cites W2120343562 @default.
• W2016385907 cites W2125413404 @default.
• W2016385907 cites W2126546063 @default.
• W2016385907 cites W2133622905 @default.
• W2016385907 cites W2139343988 @default.
• W2016385907 cites W2140742736 @default.
• W2016385907 cites W2141817082 @default.
• W2016385907 cites W2144692033 @default.
• W2016385907 cites W2146921865 @default.
• W2016385907 cites W2151647473 @default.
• W2016385907 cites W2168463237 @default.
• W2016385907 cites W2172255908 @default.
• W2016385907 doi "https://doi.org/10.1097/coh.0b013e3282fbaad0" @default.
• W2016385907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19372983" @default.
• W2016385907 hasPublicationYear "2008" @default.
• W2016385907 type Work @default.
• W2016385907 sameAs 2016385907 @default.
• W2016385907 citedByCount "17" @default.
• W2016385907 countsByYear W20163859072012 @default.
• W2016385907 countsByYear W20163859072013 @default.
• W2016385907 countsByYear W20163859072015 @default.
• W2016385907 countsByYear W20163859072018 @default.
• W2016385907 countsByYear W20163859072022 @default.
• W2016385907 crossrefType "journal-article" @default.
• W2016385907 hasAuthorship W2016385907A5021206943 @default.
• W2016385907 hasAuthorship W2016385907A5052366087 @default.
• W2016385907 hasConcept C104317684 @default.
• W2016385907 hasConcept C142462285 @default.
• W2016385907 hasConcept C142724271 @default.
• W2016385907 hasConcept C14430832 @default.
• W2016385907 hasConcept C156719811 @default.
• W2016385907 hasConcept C159047783 @default.
• W2016385907 hasConcept C181199279 @default.
• W2016385907 hasConcept C2776714187 @default.
• W2016385907 hasConcept C2777302000 @default.
• W2016385907 hasConcept C2777351918 @default.
• W2016385907 hasConcept C2779130552 @default.
• W2016385907 hasConcept C2780035454 @default.
• W2016385907 hasConcept C2780345285 @default.
• W2016385907 hasConcept C2781069245 @default.
• W2016385907 hasConcept C2993143319 @default.
• W2016385907 hasConcept C3013748606 @default.
• W2016385907 hasConcept C49105822 @default.
• W2016385907 hasConcept C54355233 @default.
• W2016385907 hasConcept C55493867 @default.
• W2016385907 hasConcept C71924100 @default.
• W2016385907 hasConcept C86803240 @default.
• W2016385907 hasConcept C98274493 @default.
• W2016385907 hasConceptScore W2016385907C104317684 @default.
• W2016385907 hasConceptScore W2016385907C142462285 @default.
• W2016385907 hasConceptScore W2016385907C142724271 @default.
• W2016385907 hasConceptScore W2016385907C14430832 @default.
• W2016385907 hasConceptScore W2016385907C156719811 @default.
• W2016385907 hasConceptScore W2016385907C159047783 @default.
• W2016385907 hasConceptScore W2016385907C181199279 @default.
• W2016385907 hasConceptScore W2016385907C2776714187 @default.
• W2016385907 hasConceptScore W2016385907C2777302000 @default.
• W2016385907 hasConceptScore W2016385907C2777351918 @default.
• W2016385907 hasConceptScore W2016385907C2779130552 @default.
• W2016385907 hasConceptScore W2016385907C2780035454 @default.
• W2016385907 hasConceptScore W2016385907C2780345285 @default.
• W2016385907 hasConceptScore W2016385907C2781069245 @default.
• W2016385907 hasConceptScore W2016385907C2993143319 @default.
• W2016385907 hasConceptScore W2016385907C3013748606 @default.

• next